File Name
-
..——
-
ACS_Risk_Biomarkers_Significantly_Increase_After_mRNA_COVID-19_Vaccine - The_Cardiology_Advisor.pdf161.37KB2021-11-21 11:39:36Abstract 10712_ mRNA_COVID_Vaccines_Dramatically_Increase_Endothelial_Inflammatory_Markers_and_ACS_Risk_as_Measured_by_the_PULS_Cardiac_Test_ a_Warning _ Circulation.pdf88.26KB2021-11-21 11:43:49Antibody-dependent_enhancement_(ADE)_and_SARS-CoV-2_vaccines_and_therapies_(Wen_Shi_Lee_et_al)_Nature_Microbiology.pdf1.65MB2021-04-08 17:46:14Antibody_evolution_after_SARS-CoV-2_mRNA_Vaccination_Cho_et_al_July_29_2021.pdf5.81MB2021-07-30 11:54:05Are_COVID-19_Vaccines_in_Pregnancy_as_Safe_and_Effective_as_the_U.S_Government_Medical_Organizations_and_Pharmaceutical_Industry_Claim_(Thorp_et_al)_preprints202406.2062.v1_June_2024.pdf2.72MB2025-01-24 10:19:48COVID-19_RNA_Based_Vaccines_and_the_Risk_of_Prion_Disease_J._Bart_Classen_Jan_2021_Journal_of_Microbiology_+_Infectious_Diseases.pdf301.29KB2021-02-14 12:53:54COVID-19_Vaccine_mRNA_Biodistribution_Maternal_and_Fetal_Exposure_Risks_(Zhong_et_al)_American_Journal_of_Reproductive_Immunology_October_2024.pdf244.57KB2025-01-24 10:25:17COVID-19_Vaccines_-_A_Risk_Factor_for_Cerebral_Thrombotic_Syndromes_(Rogers_et_al)_IJIRMS_Vol.9_Iss.11_November_2024.pdf350.61KB2024-11-08 11:55:50Circulating_SARS-CoV-2_Vaccine_Antigen_Detected_in_the_Plasma_of_mRNA-1273_Vaccine_Recipients_(Ogata et al) May_2021.pdf614.34KB2021-05-29 14:17:43Comparing_SARS-CoV-2_natural_immunity_to_vaccine-induced_immunity_reinfections_versus_breakthrough_infections_(Gazit_et_al)_August_2021-2021.08.24.21262415v1.full.pdf151.97KB2021-12-11 17:37:03Comprehensive_investigations_revealed_consistent_pathophysiological_alterations_after_vaccination_with_COVID-19_vaccines_(Jiping_Liu_et_al)_Cell_Discovery_2021-10-26.pdf3.58MB2021-10-31 08:16:41Covid-19_Breakthrough_Infections_in_Vaccinated_Health_Care_Workers_Moriah_Bergwerk_et_al_(NEJM_July_2021).pdf262.34KB2021-08-10 13:53:14Differences_in_Vaccine_and_SARS-CoV-2_Replication_Derived_mRNA-Implications_for_Cell_Biology_and_Future_Disease_11-24-21.Submit-0SF-2_(McKernan_+_McCullough).pdf3.58MB2021-12-11 11:55:12Durability_of_Transgene_Expression_and_Vector_Integration_-_Recombinant_SV40-Derived_Gene_Therapy_Vectors_(Strayer_et_al)_Molecular_Therapy_Vol.6_No.2_August_2002.pdf1.36MB2025-01-25 21:41:25Early_effectiveness_of_COVID-19_vaccination_with_BNT162b2_mRNA_vaccine_and_ChAdOx1_adenovirus_vector_vaccine_on_symptomatic_disease_hospitalisations_+_mortality_in_older_adults_in_England.pdf399.55KB2021-03-05 13:38:10Effectiveness_of_Covid-19_vaccination_against_risk_of_symptomatic_infection_hospitalization_and_death_up_to_9_months_a_Swedish_total_population_cohort_study_(Nordstrom_et_al)-SSRN-id3949410.pdf962.45KB2021-11-25 09:58:51Efficacy_of_the_NVX-CoV2373_Covid-19_Vaccine_Against_the_B.1.1.7_Variant_(Heath_et_al)_May_2021-2021.05.13.21256639v1.full.pdf1.93MB2021-06-01 14:41:57Efficacy_of_the_mRNA-1273_SARS-CoV-2_Vaccine_at_Completion_of_Blinded_Phase_(NEJM_October_2021)_Hana_et_al_nejmoa2113017.pdf854.67KB2021-12-06 14:30:58Evaluating_the_number_of_unvaccinated_people_needed_to_exclude_to_prevent_SARS-CoV-2_transmissions_(Prosser_et_al)_December_2021-2021.12.08.21267162v1.full.pdf870.77KB2021-12-12 14:42:39Exploring_COVID-19_vaccine_adverse_events_among_pregnant_women_-_a_cross-sectional_study_2022_(Amer_et_al)_2024 Vol. 12_1�25_(10.1177_25151355241285594).pdf965.24KB2025-01-24 10:21:02Immune_imprinting_breadth_of_variant_recognition_and_germinal_center_response_in_human_SARS-CoV-2_infection_and_vaccination-(Rotgen_et_al-Cell_magazine)_March_2022_issue.pdf32.08MB2022-02-16 12:28:15Informed_consent_disclosure_to_vaccine_trial_subjects_of_risk_of_COVID-19_vaccines_worsening_clinical_disease_Wiley_ijcp.13795.pdf290.49KB2021-03-05 16:20:38Judicial_Precedents_and_Vaccine_Mandates_Aaron_Kheriaty_MD_2021-10-13_Human_Flourishing.pdf610.36KB2021-10-13 07:45:25Lancet_Letter_Demolishes_Vaccination_Igor_Chudov_Nov_2021.pdf205.71KB2021-12-01 09:41:11Mechanisms_of_SARS-CoV-2_Evolution_Revealing_Vaccine-Resistant_Mutations_in_Europe_and_America_(Wang_et_al)_PubMed_Dec_2021.pdf80.77KB2021-12-08 09:54:59Moderna_mRNA_Vaccine_study_done_pub_2017_showing_LNP_mRNA_Vaccines_do_NOT_stay_at_the_site_of_injection_(Bahl_et_al).pdf8.44MB2021-08-16 12:03:59Phase_I_II_study_of_COVID-19_RNA_vaccine_BNT162b1_in_adults_(Mulligan_et-al)_Aug_2020.pdf2.31MB2021-02-04 19:22:57Placental_Histopathological_Changes_and_the_Level_of_Anti-Spike_Antibody_After_Covid-19_Vaccination_During_Pregnancy_(Heidary_et_al)_Journal_of_Reproduction_&_Infertility_Vol.25_Issue_no.3_May_2024_JRI-25-231.pdf341.97KB2025-01-24 10:21:39Pseudouridine guides germline small RNA transport and epigenetic inheritances_Nature_September_2024_41594-024-01392-6.pdf17.88MB2024-12-30 17:47:09REACT-2_Round_8_increasing_prevalence_of_SARS-CoV-2_antibodies_demonstrate_impact_of_the_second_wave_and_of_vaccine_roll-out_in_England_(Ward_et_al)_Feb_2021.pdf2.05MB2021-03-18 16:22:06Review_of_COVID-19_Vaccines_and_the_Risk_of_Chronic_Adverse_Events_Including_Neurological_Degeneration_Classen_March_24_2021.pdf326.98KB2021-08-31 12:36:26Risk_of_Myopericarditis_following_COVID-19_mRNA_vaccination_in_a_Large_Integrated_Health_System_A_Comparison_of_Completeness_and_Timeliness_of_Two_Methods_(Sharif_et_al)_December_2021-2021.12.21.21268209v1.full.pdf788.80KB2022-01-10 13:38:48SARS-CoV-2_Prion-Like_Domains_in_Spike_Proteins_Enable_Higher_Affinity_to_ACE2_(Tetz + Tetz April_2020)_Human_Microbiology_Institute-preprints202003.0422.v1.pdf506.49KB2021-04-07 18:58:05SARS-CoV-2_Spike_Protein_Elicits_Cell_Signaling_in_Human_Host Cells_Implications_for_Possible_Consequences_of_COVID-19_Vaccines_(Suzuki_et_al_MDPI)_January_2021.pdf690.84KB2021-06-03 14:20:41SARS-CoV-2_mRNA_vaccine_design_enabled_by_prototype_pathogen_preparedness_(Corbett_et_al)_Aug_2020_s41586-020-2622-0.pdf9.17MB2020-11-16 11:16:51SARS-CoV-2_spike_protein_S1_induces_fibrin(ogen)_resistant_to_fibrinolysis_Implications_for_microclot_formation_in_COVID-19_Grobbelaar_et_al)_March_2021.pdf2.28MB2021-06-04 11:27:38Scanning_+_Transmission_Electron_Microscopy_Reveals_Graphene_Oxide_in_CoV-19_Vaccines_(Robert_O_Young)_Aug_20_2021.pdf35.14MB2021-09-03 14:10:48Study_on_electromagnetism_of_vaccinated_persons_in_Luxembourg_(Mamer)_June_06_2021.pdf225.08KB2021-06-28 11:29:11Study_to_Describe_the_Safety_Tolerability_Immunogenicity_+_Efficacy_of_RNA_Vaccine_Candidates_Against_COVID-19_in_Healthy_Individuals_ClinicalTrials.gov.pdf337.49KB2021-02-04 19:21:43Temporal Analysis of Vaccine Adverse Effects for Causation Inference_preprints202312.1385.v2.pdf1.51MB2024-12-30 17:11:39The_epidemiological_relevance_of_the_COVID-19-vaccinated_population_is_increasing_The_Lancet_(Gunter_Kampf_2021-11-03).pdf358.71KB2021-12-01 09:39:50US_COVID-19_Vaccines_Proven_to_Cause_More_Harm_than_Good_Based_on_Pivotal_Clinical_Trial_Data_(J.Bart_Classen)_August_25_2021.pdf377.64KB2021-08-31 10:58:54Vaccine_Induced_Covid-19_Mimicry_Syndrome_Spike_protein_variants_that_may_cause_thromboembolic_events_Kowarz_et_al_(May_2021).pdf776.21KB2021-05-29 09:47:30View_of_Worse_Than_the_Disease_ Reviewing_Some_Possible_Unintended_Consequences_of_the_mRNA_Vaccines_Against_COVID-19_(Seneff_+_Nigh).pdf12.78MB2021-05-15 09:27:36